期刊文献+

中、重度卵巢过度刺激综合征45例临床分析 被引量:6

Clinical analysis of 45 cases with moderate and severeovarian hyperstimulation syndrome
下载PDF
导出
摘要 目的:总结体外受精-胚胎移植(in vitro fertilization-embryo transfer,IVF-ET)过程中卵巢过度刺激综合征(ovarian hyperstimulation syndrome,OHSS)的临床特点、治疗和预防。方法:回顾性分析我院生殖中心2010年1月至2014年10月行IVF-ET中发生的中、重度OHSS而进行住院治疗的45例患者的临床资料。结果:45例研究对象中,ET妊娠组28例,未ET组17例,中度OHSS患者31例,重度OHSS患者14例。ET妊娠组重度OHSS发生率42.86%(12/28)与未ET组11.76%(2/17)比较,差异有统计学意义(P<0.05)。ET妊娠组的住院时间、腹穿率、白蛋白使用量均高于未ET组,差异均有统计学意义(P<0.05)。ET妊娠组,1例重度OHSS患者并发锁骨下静脉血栓,低分子肝素抗凝治疗效果良好。结论:在促排卵药物的应用过程中,应注意预防OHSS的发生,对有高危因素OHSS患者可行胚胎冷冻保存。对于中、重度OHSS患者应严密监护治疗。 Objectives: To investigate the clinical characteristics,therapy and prevention of ovarian hyperstimulation syndrome( OHSS) in vitro fertilization- embryo transfer( IVF- ET). Methods: Data of 45 cases of moderate and severe OHSS after IVF- ET from January 2010 to October 2014 in Peking University First Hospital were analyzed retrospectively. Results: 45 cases were divided into ET- pregnancy group( n = 28) and non- ET group( n = 17). There were 31 cases of moderate OHSS and 14 cases of severe OHSS. The occurrence rate of severe OHSS was( 42. 86%,12 /28) in ET- pregnancy group and( 11. 76%,2 /17) in non- ET group. The differ-ence was statistically significant( P〈 0. 05). The total course of OHSS,the rate of abdominocentesis and the dose of albumin in ET- pregnancy group were significantly higher than these of non- ET group( P〈 0. 05). In ET-pregnancy group,one severe OHSS patient complicated with subclavian vein thrombosis got a good therapeutic effect of low molecular weight heparin. Conclusion: We should pay attention to prevent the occurrence of OHSS when enhancing ovulation. Cryopreserving all embryos is an effective choice for patients with high- risk factor of OHSS. Intensive care is necessary in the treatment of moderate to severe OHSS patients.
出处 《中国性科学》 2015年第4期102-106,共5页 Chinese Journal of Human Sexuality
关键词 卵巢过度刺激综合征 体外受精-胚胎移植 治疗与预防 Ovarian hyperstimulation syndrome In vitro fertilization-embryo transfer Treatment and prevention
  • 相关文献

参考文献30

  • 1Mathur RS,Akande AV,Keay SD,et al.Distinction between early and late ovarian hyperstimulation syndrome.Fertility and sterility,2000,73(5):901-907.
  • 2Golan A,Ron-el R,Herman A,et al.Ovarian hyperstimulation syndrome:an update review.Obstetrical&gynecological survey,1989,44(6):430-440.
  • 3Humaidan P,Quartarolo J,Papanikolaou EG.Preventing ovarian hyperstimulation syndrome:guidance for the clinician.Fertility and sterility,2010,94(2):389-400.
  • 4Delvigne A,Rozenberg S.Epidemiology and prevention of ovarian hyperstimulation syndrome(OHSS):a review.Human reproduction update,2002,8(6):559-577.
  • 5Swanton A,Storey L,Mcveigh E,et al.IVF outcome in women with PCOS,PCO and normal ovarian morphology.European journal of obstetrics,gynecology,and reproductive biology,2010,149(1):68-71.
  • 6Lainas GT,Kolibianakis EM,Sfontouris IA,et al.Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.Human reproduction(Oxford,England),2013,28(7):1929-1942.
  • 7Lainas TG,Sfontouris IA,Zorzovilis IZ,et al.Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF:a prospective randomised controlled trial(RCT).Human reproduction(Oxford,England),2010,25(3):683-689.
  • 8Stadtmauer LA,Sarhan A,Duran EH,et al.The impact of a gonadotropin-releasing hormone antagonist on gonadotropin ovulation induction cycles in women with polycystic ovary syndrome:a prospective randomized study.Fertility and sterility,2011,95(1):216-220.
  • 9Al-inany HG,Youssef MA,Aboulghar M,et al.Gonadotrophinreleasing hormone antagonists for assisted reproductive technology.The Cochrane database of systematic reviews,2011(5):1750.
  • 10吴香春.多囊卵巢综合症患者不同促排卵方案临床疗效分析[J].中国性科学,2014,23(5):35-37. 被引量:42

二级参考文献46

  • 1阎艳丽,王鑫国,宋晓宇,李清,陈静,张莉芳.当归芍药散对高脂血症家兔脂代谢及血液流变学的影响[J].辽宁中医杂志,2005,32(2):170-171. 被引量:17
  • 2陈晓燕,曹缵孙,毛文军.HMG-HCG促排卵治疗席汉氏综合征[J].西安医科大学学报,1995,16(4):403-405. 被引量:12
  • 3Felverbaum R, Diedrich K. Ovarian stimulation in ART:use ofGnRH - antagonists. FertilReprodMed. Proceedings of the XVIWorld Congress on Fertility and Sterility. San Francis- co, 1998:113-124.
  • 4Hammadeh ME, Fischer - Hammadeh C, Georg T, et al . Comparison between cytokine concentration in follicular flu- id of poor and high responder patients and their influence of ICSI - outcome. Am J Reprod Immunol. 2003, 50(2) : 131 - 136.
  • 5Hammadeh ME, Fischer - Hammadeh C, Hoffmeister H, et al. Relationship between cytokine concentrations ( FGF, sICAM - 1 and SCF) in serum, follicular fluid and ICSI outcome. Am J Reprod Immunol,2004,51 ( 1 ) :81 -85.
  • 6Mendoza C, Cremades N, Ruiz - RequenaE, etal. Relation- ship between fertilization results after intracytoplasmic sperm injection, and intrafollicul ar steroid, pituitary hor- mone and cytokine concentrations. Hum Reprod, 1999, 14 (3) :628 -635.
  • 7Mendoza C, Ruiz - Requena E, Ortega E, et al. Follicular fluid markers of oocyte developmental potential. Hum Re- prod,2002,17(4) :1017 - 1022.
  • 8Sanja Vujisicl, Snjeiana Zidovec Lepej, Ivana Emedi, et al. Ovarian follicular concentration of IL - 12, IL - 15, IL - 18 and p40 subunit of IL - 12 and IL - 23. Human Re- production,2006, (26) 10 : 2650 - 2655.
  • 9Aili Sarapik, Agne Vehhut, KadriHaller - Kikkatalo, etal. Follicular Proinflammatory Cytokines and Chemokines as Markers of IVF Success. Clinical and Developmental Immu- nology. 2012 : 1 - 10.
  • 10Gutman G, Soussan- Gutman L, MalcovM, et al. Intedeu- kin - 18 is high in the serum of IVF pregnancies with ovari- an hyperstimulation syndrome . Am J Reprod Immunol. 2004,51(5) :381 -384.

共引文献55

同被引文献65

  • 1陈洁.卵巢过度刺激综合征38例临床治疗观察[J].中外医疗,2008,27(24):35-36. 被引量:2
  • 2谈勇.卵巢过度刺激综合征的辨证论治[J].江苏中医药,2006,27(3):13-14. 被引量:19
  • 3刘凤云,吴先哲,张敏,郭广洲,黄志欣.益肾利水方对卵巢过度刺激综合征患者血管通透性的影响[J].中医杂志,2007,48(11):989-991. 被引量:15
  • 4佟丽丽,满玉晶,吴效科.中药辅助治疗重度卵巢过度刺激综合征1例[J].中国医药导报,2007,4(12X):236-237. 被引量:8
  • 5Smith V,Osianlis T,Vollenhoven B.Prevention of ovarian hyperstimulation syndrome:a review[J].Obstet Gynecol Int,2015,2015:514159.
  • 6Nardo LG,Bosch E,Lambalk CB,et al.Controlled ovarian hyperstimulation regimens:a review of the available evidence for clinical practice.Produced on behalf of the BFS Policy and Practice Committee.Hum Fertil(Camb),2013,16(3):144-150.
  • 7Nastri CO,Teixeira DM,Moroni RM,et al.Ovarian hyperstimulation syndrome:pathophysiology,staging,prediction and prevention.Ultrasound Obstet Gynecol,2015,45(4):377-393.
  • 8Fiedler K,Ezcurra D.Predicting and preventing ovarian hyperstimulation syndrome(OHSS):the need for individualized not standardized treatment.Reproductive Biology and Endocrinology:RB&E,2012(10):32.
  • 9D'Angelo A.Ovarian hyperstimulation syndrome prevention strategies:cryopreservation of all embryos.Seminars in Reproductive Medicine,2010,28(6):513-518.
  • 10Fatemi HM,Popovic-Todorovic B,Humaidan P,et al.Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone(GnRH)agonist trigger and"freeze-all"approach in GnRH antagonist protocol.Fertility and Sterility,2014,101(4):1008-1011.

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部